Diese Arbeit wurde von R &amp; D Systems, Inc. finanziert

Ein. Probenvorbereitung <ol><li> Sammle Lysaten aus unbehandelten, Ligand behandelt, oder Inhibitor und Ligand behandelten Zellen nach den Richtlinien im Human Phospho-RTK Array Datenblatt. Der Lysepuffer hat für dieses Kit optimiert. Die Substitution von anderen Lysepuffern kann sich auf die endgültige Leistung des Arrays. Einen proteolytischen Abbau Probe zu verhindern, fügt 10 ug / ml Aprotinin, 10 ug / ml Leupeptin und 10 ug / ml Pepstatin A zum Volumen Lysepuffer für jede Zelle Lysat-Zubereitung frischer für jede Anwendung nicht erforderlich. </li><li> Lysat Konzentration sollte unter Verwendung eines Bicinchoninsäure (BCA)-Assay werden. Probenkonzentration kann empirisch für eine optimale Empfindlichkeit und einen niedrigen Hintergrund eingestellt werden. Ein Bereich von 100-300 ug Lysat wird als eine anfängliche Startpunkt empfohlen. </li><li> Einfrieren / Auftauen der Proben sollte vermieden werden und fachgerechte Lagerung von Lysaten wird für eine optimale Leistung benötigt. Eingefrorene Lysatproben auf Eis. </li></ol><ol><li> Bringen Sie alle Kit-Komponenten auf Raumtemperatur vor dem Gebrauch. Um Verunreinigungen zu vermeiden, tragen Sie Handschuhe während der Durchführung der Verfahren. </li><li> Pipette 2,0 ml Array Buffer 1 in jedes Well der 4-Well Multi-Teller verwendet werden. Array Puffer 1 dient als Blockpuffer. </li><li> Mit Flachbild-Spitze Pinzette jede Membran aus zwischen den Schutzfolien und in einen Brunnen der 4-Well Multi-Gericht verwendet werden. Die Array-Nummer muss nach oben zeigen. </li><li> Beim Kontakt mit Array Puffer 1 wird der blaue Farbstoff aus den Flecken verschwinden, aber die die Fang-Antikörper in ihrem spezifischen Stellen beibehalten. </li><li> Inkubieren für 1 Stunde auf einem schaukelnden Plattform. Richten Sie das Fach, so dass jedes Array rocks Ende in seiner gut enden. Die Oberfläche des Array sollte vollständig benetzt werden und fallen unter Blockpuffer. </li><li> Während die Membranen sperren, verdünnte die gewünschte Menge des zellulären Lysats auf ein Endvolumen von 1,5 ml mit Puffer 1 Array. </li> &lt;li&gt; Aspirate Array Buffer 1 aus den Brunnen der 4-Well Multi-Schüssel und fügen verdünnten Lysats Lösungen. Setzen Sie den Deckel auf dem 4-Well Multi-Gericht. </li><li> Inkubieren über Nacht bei 2-8 ° C auf einem Schüttler Plattform. Eine kürzere Inkubationszeit kann verwendet werden, wenn eine optimale Empfindlichkeit nicht erforderlich ist. </li><li> Entfernen Sie vorsichtig jede Membran aus dem 4-Well Multi-Teller und Ort in einzelne Kunststoff-Behälter mit 20 ml 1X Waschpuffer. Das 4-Well Multi-Gericht kann nicht verwendet werden, um Waschschritte abzuschließen. Spülen Sie das 4-Well Multi-Schale mit destilliertem Wasser und trocknen. </li><li> Waschen Sie jede Membran mit 1X Waschpuffer für 10 min auf einem Wippschüttler Shaker. Wiederholen Sie zwei Mal für insgesamt 3 Wäschen. </li><li> Verdünnen Sie die Anti-Phospho-Tyrosin-Meerrettichperoxidase (HRP) Detektionspuffer in 1X Array Buffer 2 mit dem Verdünnungsfaktor auf dem Flaschenetikett. Pipette 2,0 ml der verdünnten Lösung in jede Vertiefung der 4-Well Multi-Gericht. </li><li> Entfernen Sie vorsichtig jede Membran aus ihrer Wäsche-Container.Überschüssige Puffer von der Membran abtropfen und gibt die Membran an der 4-Well Multi-Schale mit der verdünnten Anti-Phospho-Tyrosin-HRP. Die Vertiefungen mit dem Deckel. </li><li> Inkubieren für 2 Stunden bei Raumtemperatur auf einem schaukelnden Plattform. </li><li> Waschen jedes Array wie zuvor beschrieben. </li><li> Führen Sie die verbleibenden Schritte ohne Unterbrechung. Entfernen Sie vorsichtig jede Membran aus ihrer Wäsche-Container. Überschüssige Puffer aus der Membran durch Blotten der unteren Kante auf Saugpapier abzulassen. Platzieren Sie jede Membran auf eine Plastikfolie Protektor mit der Identifikationsnummer nach oben. </li><li> Je 1 ml der vorbereiteten Chemi Reagenzienmix gleichmäßig auf jeder Membran. Verwendung von weniger als 1 ml Reagenz Chemi-Mischung pro Membran kann zu einer unvollständigen Membran Deckung kommen. Substitution einiger hoher Intensität Chemilumineszenz Reagenzien für Chemi Reagenzien 1 und 2 kann entweder erhöht Hintergrund oder verminderten Abhängigkeit von dem Reagenz. </li><li> Vorsichtig mit einer KunststoffabdeckungKlarsichthülle. Gently glätten alle Luftblasen und sicherzustellen, Chemi Reagent Mix gleichmäßig in alle Ecken jeder Membran verteilt. Inkubation für 1 min. </li><li> Position Papierhandtücher auf der Oberseite und Seiten aus Kunststoff Klarsichthülle mit den Membranen und sorgfältig auspressen Chemi Reagent Mix. </li><li> Entfernen Sie die obere Plastikfolie Beschützer und legen Sie es vorsichtig eine absorbierende lab on top der Membranen abtupfen alle verbleibenden Chemi Reagent Mix wischen. </li><li> Verlassen Membranen auf der Unterseite Plastikfolie Beschützer, decken die Membranen mit Plastikfolie kümmert sanft glätten alle Luftblasen. Wickeln des überschüssigen Plastikfolie um die Rückseite des Blattes, so daß die Schutzfolie Membranen und Klarsichthülle vollständig umwickelt. </li><li> Platzieren Sie die Membranen mit den Identifikationsnummern nach oben, in einer Autoradiographie Filmkassette, die nicht mit radioaktiven Isotop Detektion verwendet wird. </li><li> Aussetzen Kodak BioMax Light Film für 1-10 min. Mehrfachbelichtungen sind empfbeendet. Alternativ können die Bilder gesammelt, indem ein Chemilumineszenz kompatibel Imager wie die Carestream Health werden Image Station 4000mm PRO. </li></ol> 3. Data Analysis <ol><li> Positive Signale zur entwickelten Film gesehen kann schnell, indem die Transparenz Überlagerung auf dem Array Bild und dass es in die Paare von Referenzspots in den Ecken zu diesem Zweck bedruckt identifiziert werden. Die abgestempelte Identifikationsnummer auf dem Array sollte auf der linken hatten platziert werden. Die Lage der Kontrollen und Fänger-Antikörper befindet sich im Anhang des Human Phospho-RTK Array Datenblatt aufgeführt. </li><li> Pixel Dichten auf entwickelten Film können mithilfe einer Übertragung-mode-Scanner wie dem Epson Perfection V750 PRO werden. </li><li> Erstellen Sie eine Vorlage zur Pixeldichte in jedem Punkt des Arrays unter Verwendung eines geeigneten Bildanalyse-Software-Programm zu analysieren. Kompatiblen Programmen gehören ImageQuant oder ArrayVision Software von GE, Western Vision software mit Vorlagen spezifische Profiler Arrays, BioRad Quantity One, Adobe Photoshop, NIH ImageJ und Protein Einfache AlphaView Proteome. </li><li> Exportieren Signalwerte eine Spreadsheet-Datei für die Manipulation in einem Programm wie Microsoft Excel. </li><li> Ermitteln der durchschnittlichen Signalleistung (Pixeldichte) des Paares von doppelten Spots Darstellen jedes RTK. </li><li> Subtrahieren einer gemittelten Signal von jedem Ort. Verwenden eines Signals von einer freien Fläche des Arrays oder negative Kontrolle Spots als Hintergrund-Wert. </li><li> Vergleichen entsprechender Signale auf unterschiedlichen Arrays, um die relative Änderung der RTK Phosphorylierung Ebenen zwischen den Proben zu bestimmen. </li></ol> 4. Repräsentative Ergebnisse Dieses Protokoll wird veranschaulicht, wie das Human Phospho-RTK-Array verwendet werden, um die Wirkungen von Ligand Stimulation und Inhibitoren auf RTK Phosphorylierung screenen. In Abbildung 1 sind die Daten für MDA-MB-453-Zellen, die unbehandelt gezeigt, mit 100 ng/ Ml rhNRG-β1/HRG-β1 (HRG-β1) für 5 min, oder mit bekannten ErbB-Familie Inhibitoren 8-11 vor HRGβ1 Behandlung vorbehandelt werden. Für Inhibitor Experimente wurden die Zellen mit 1 uM HDS 029, 200 nM PD 153.035 oder 158.780 PD 200 nM in SFM für drei Stunden inkubiert. Jedes Array wurde mit 100 ug Lysat inkubiert. Eine Zunahme der Phosphorylierung ist für ErbB2, ErbB3 beobachtet und ErbB4 Capture Flecken beim Vergleich mit unbehandelten Zellen HRG-β1 behandelt MDA-MB-453-Zellen. Die Behandlung der Zellen mit allen drei ErbB-Familie selektive Inhibitoren vor HRG-β1 Inkubation verursachte Verringerung der ErbB2, ErbB3, ErbB4 und Phosphorylierung. In Abbildung 2 sind die Daten für Kato III-Zellen bekannt, die RTK FGF R2 überexprimieren gezeigt. In diesem Satz von Experimenten waren Kato III-Zellen unbehandelte, mit 100 ng / ml rhFGF sauer (FGF) und 1 ug / ml Heparin, oder vorbehandelt mit FGF R selektive Inhibitoren 12-15 vor der Behandlung mitFGF und Heparin. Die Inhibitoren PD173074, PD 161.570, 166.285 und PD wurden bei einer Konzentration von 1 uM verwendet und inkubiert mit den Kato III-Zellen für 3 h in serumfreiem Medium. Während es konstitutiven Phosphorylierung von sowohl EGF und FGF R R2 in unbehandelten KATO III-Zellen, einem Anstieg der FGF R2 Phosphorylierung wurde auf FGF Behandlung beobachtet. Inkubieren der Zellen mit PD 173.074 ergab PD 161.570 oder 166.285 PD einer verringerten FGF R2 und EGF R Phosphorylierung. Obwohl diese bekannten Inhibitoren auf die Phosphorylierung von FGF R Familienmitglieder zeigen diese Ergebnisse, die Nützlichkeit des Human Phospho-RTK-Array für das Überwachen der Wirkung einer bestimmten Konzentration des Inhibitors auf andere RTKs, wie EGF R in diesem Fall haben kann. <img alt="Abbildung 1" fo:content-width="4.5in" fo:src="/files/ftp_upload/4199/4199fig1highres.jpg" src="/files/ftp_upload/4199/4199fig1.jpg" /> Abbildung 1. Induktion und Hemmung der Rezeptorentor Tyrosin-Kinase-Phosphorylierung in Brustkrebszellen. Array Bilder von Proteome Profiler Menschliche Phospho-RTK-Arrays sowie die entsprechenden Histogramm Profilen gezeigt. MDA-MB-453-Zellen waren unbehandelt oder mit Inhibitoren RTK gefolgt von Behandlung mit NRG-β1/HRG-β1. Das Array wurde verwendet, um die Auswirkungen der Inhibitoren auf die Kinase-Phosphorylierung in MDA-MB-453-Zellen zu überwachen. <a href="http://www.jove.com/files/ftp_upload/4199/4199fig1large.jpg" target="_blank">Klicken Sie hier für eine größere Abbildung zu sehen</a> . <img alt="Abbildung 2" fo:content-width="4.5in" fo:src="/files/ftp_upload/4199/4199fig2highres.jpg" src="/files/ftp_upload/4199/4199fig2.jpg" /> Abbildung 2. Induktion und Hemmung der Rezeptor-Tyrosin-Kinase-Phosphorylierung in Magenkarzinomzellen. Array von Bildern von einem Proteome Profiler Menschliche Phospho-RTK-Array und den entsprechenden Histogramm-Profile angezeigt. Kato III-Zellen waren untreated oder behandelt mit RTK-Inhibitoren durch Behandlung mit FGF saurer und Heparin gefolgt. <a href="http://www.jove.com/files/ftp_upload/4199/4199fig2large.jpg" target="_blank">Klicken Sie hier für eine größere Abbildung zu sehen</a> . Referenzen <ol><li> Henriksson, ML, Edin, S., Dahlin, AM, Oldenborg, PA, Oberg, A., Van Guelpen, B., Rutegard, J., Stenling, R., &amp; Palmqvist, aktivieren R. Darmkrebs benachbarten Zellen Fibroblasten resultierenden in FGF1/FGFR3 Signalisierung und erhöhten Invasion. Am. J. Pathol. 178, 1387-1394 (2011). </li><li> Morishita, A., Gong, J., Nomura, T., Yoshida, H., Izuishi, K., Suzuki, Y., Kushida, Y., Haba, R., D&#39;Armiento, J., &amp; Masaki, T. Die Verwendung von Protein-Arrays zu identifizieren anzielbare Rezeptortyrosinkinasen zur Behandlung von menschlichen Dickdarmkrebs. Int. J. Oncol. 37, 829-835 (2010). </li><li> Agaram, NP, Laquaglia, MP, Ustun, B., Guo, T., Wong, GC, Socci, ND, Maki, RG,DeMatteo, RP, Besmer, P., &amp; Antonescu, CR Molekulare Charakterisierung der pädiatrischen gastrointestinalen Stromatumoren. Clin. Cancer Res. 14, 3204-3215 (2008). </li><li> Stommel, JM, Kimmelman, AC, Ying, H., Nabioullin, R., Ponugoti, AH, Wiedemeyer, R., Stegh, AH, Bradner, JE, Ligon, KL, Brennan, C., Chin, L., &amp; DePinho wirkt RA Koaktivierung von Rezeptortyrosinkinasen die Reaktion von Tumorzellen an zielgerichtete Therapien. Science. 318, 287-290 (2007). </li><li> Agarwal, S., Zerillo, C., Kolmakova, J., Christensen, JG, Harris, LN, Rimm, DL, DiGiovanna, MP, &amp; Stern, DF Verband konstitutiv aktivierte Hepatozyten-Wachstumsfaktor-Rezeptor (Met) mit einer Resistenz gegen ein Dual EGFR/Her2 Inhibitor in non-small-cell lung cancer Zellen. Br. J. Cancer. 100, 941-949 (2009). </li><li> Dewaele, BM, Floris, G., Finalet-Ferreiro, J., Fletcher, CD, Coindre, JM, Guillou, L., Hogendoorn, PC, Wozniak, A., Vanspauwen, V., Schöffski, P., MARYNEN, P., Vandenbergh, P., Sciot, R., &amp; Debiec-Rychter, M. Co-activated PDGFRA und EGFR sind potentielle therapeutische Targets in der Intima-Sarkom. Cancer Res. 70, 7304-7314 (2010). </li><li> Yoon, YK, Kim, HP, Han, SW, Hur, HS, Oh, DY, Im, SA, Bang, YJ, &amp; Kim, TY Kombination von EGFR und MEK1 / 2 Inhibitor synergistische Effekte durch Unterdrückung EGFR/HER3-dependent AKT-Aktivierung in menschlichen Magen Krebszellen. Mol. Cancer Ther. 8, 2526-2536 (2009). </li><li> Fry, DW, Nelson, JM, Slintak, V., Keller, PR, Rewcastle, GW, Denny, WA, Zhou, H., &amp; Brücken, AJ biochemische und antiproliferativen Eigenschaften von 4 - [Ar (alk) yl-amino] Pyridopyrimidine, eine neue Wirkstoffklasse potenter und spezifischer epidermalen Wachstumsfaktor-Rezeptor-Tyrosinkinase-Inhibitor. Biochem. Pharmacol. 54, 877-887 (1997). </li><li> Bos,M., Mendelsohn, J., Kim verhindert, YM, Albanell, J., Fry, DW, und Baselga, J. PD153035, einem Tyrosinkinase-Inhibitor, den epidermalen Wachstumsfaktor-Rezeptor-Aktivierung und hemmt das Wachstum von Krebszellen in einem Rezeptor zahlenmittleren abhängigen Weise. Clin. Cancer Res.. 3, 2099-2106 (1997). </li><li> Stoll, SW, Kansra, S., Peshick, S., Fry, DW, Leopold, WR, Wiesen, JF, Sibilia, M., Zhang, T., Werb, Z., Derynck, R., Wagner, EF, &amp; Elder, JT Differential Auslastung und Lokalisierung von ErbB-Rezeptor-Tyrosinkinasen in der Haut im Vergleich zu normalen und malignen Keratinozyten. Neoplasie. 3, 339-350 (2001). </li><li> Klutchko, SR, Zhou, H., Winter, RT, Tran, TP, Bridges, AJ, Althau, IW, Amato, DM, Elliott, WL, Meade, MA, Roberts, BJ, Fry, DW, Gonzales, AJ, Harvey , PJ, Nelson, JM, Sherwood, V., Han, HK, Pace, G., Smaill, JB, Denny, WA, &amp; Showalter, HD Tyrosin-Kinase-Inhibitoren. 19. 6-Alknyamides von 4-Anilinochinazoline und 4-anilinopyrido [3,4-d] pyrimidine als irreversible Hemmstoffe der ErbB-Familie von Tyrosinkinase-Rezeptoren. J. Med. Chem. 49, 1475-1485 (2006). </li><li> Kunii, K., Davis, L., Gorenstein, J., Hatch, H., Yashiro, M., Di Bacco, A., Elbi, C., &amp; Lutterbach, B. FGFR2-verstärkt Magenkrebs Zelllinien erfordern FGFR2 und ErbB3 Signalisierung für Wachstum und Überleben. Cancer Res. 68, 2340-2348 (2008). </li><li> Zhou, W., Hur, W. McDermott, U., Dutt, A., Xian, W., Ficarro, SB, Zhang, J., Sharma, SV, Brugge, J., Meyerson, M., Settleman, J . &amp; Gray, NS Struktur-geführte Ansatz zur Schaffung kovalente FGFR Inhibitoren. Chem. Biol. 17, 285-295 (2010). </li><li> Batley, BL, Doherty, AM, Hamby, JM, Lu, GH, Keller, P., Dahring, TK, Hwang, O., Crickard, K., &amp; RL Panek Inhibition der FGF-1-Rezeptor-Tyrosinkinase-Aktivität durch PD 161.570 , ein neues Protein-Tyrosinkinase-Inhibitor. Life Sci. 62 143-150 (1998). </li><li> Panek, RL, Lu GH, Klutchko, SR, Batley, BL, Darhing, TK, Hamby, JM, Hallak, H., Doherty, AM, &amp; Keiser, JA In vitro pharmakologische Charakterisierung von PD 166285, ein neues nanomolaren wirksame und breit aktives Protein-Tyrosin-Kinase-Inhibitor. J. Pharmacol. Exp. Ther. 283, 1433-1444 (1997). </li></ol>

The Human Phospho-RTK ist eine kostengünstige und schnelle Alternative zu traditionellen Methoden wie Immunpräzipitation (IP) Western für das Screening Veränderungen im RTK-Phosphorylierung. Mit dieser Methode wurden die relativen Spiegel von 42 phospho-RTKs gleichzeitig unter Verwendung einer einzelnen Probe von MDA-MB-453 oder Kato III Zelllysat gescreent. Darüber hinaus benötigt dieses Array Assay 2,5 h hands-on Zeit, so dass diese Methode viel mehr Zeit-wirksamer als die Durchführung mehrerer IP-Westerns. Durch Verwendung eines Chemilumineszenz Nachweisverfahrens, wurde keine spezielle Ausrüstung hinaus, was in der Regel verwendet, um Daten zu sammeln westlichen erforderlich. Arrays sind empfindlich und können verwendet werden, um Änderungen in der Phosphorylierung von beiden Ligand und Inhibitor Behandlung verursacht vergleichen. Diese Methode ermöglicht auch die Auswertung der Inhibitor Selektivität vorbei RTKs. Positive Ergebnisse kann weiter ausgewertet werden unter Verwendung eines quantitativen Assays wie ELISA. Um effektiv arbeiten Arrays zur Früherkennung vonin der Phosphorylierung, sollten einige wichtige experimentelle Richtlinien befolgt werden. Zunächst sollten Experimente umfassen geeignete Kontrollproben. Zum Beispiel wird in diesen Experimenten wurde die Wirkung von Inhibitoren auf MDA-MB-453 oder Kato III Lysate wurden auf Lysatproben am selben Tag hergestellt gemessen. Nur Arraydaten, die innerhalb des gleichen Experiment gesammelt wird untersucht, um zu Variationen der Signalstärke aufgrund von Unterschieden bei der Probenhandhabung, Inkubationszeit Pipette Technik oder Wash-Technik zu minimieren. Vergleichen Signalintensitäten zwischen zwei Analyten auf der gleichen Membran ist nicht zu empfehlen, da Fängerantikörpern nicht ausgewählt wurden, um parallele Affinitäten aufweisen.

<table border="1">
	<tbody>
		<tr>
			<td>Name of the reagent</td>
			<td>Company</td>
			<td>Catalogue number</td>
			<td>Comments (optional)</td>
		</tr>
		<tr>
			<td><a href="http://www.rndsystems.com/product_results.aspx?k=ary001" target="_blank">Human Phospho-RTK Array Kit</a></td>
			<td>R&amp;D Sytems</td>
			<td>ARY001</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Aprotinin</td>
			<td>Sigma</td>
			<td>A6279</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Leupeptin</td>
			<td>Tocris</td>
			<td>1167</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Pepstatin A</td>
			<td>Tocris</td>
			<td>1190</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>MDA-MB-453 cells</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Kato III cells</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td><a href="http://www.rndsystems.com/product_results.aspx?k=396-hb" target="_blank">Recombinant Human NRG1-beta 1/HRG1-beta 1 EGF Domain</a></td>
			<td>R&amp;D Systems</td>
			<td>396-HB-050</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td><a href="http://www.rndsystems.com/product_results.aspx?k=232-fa" target="_blank">Recombinant Human FGF acidic (aa 16-155)</a></td>
			<td>R&amp;D Systems</td>
			<td>232-FA-025</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Heparin</td>
			<td>Sigma</td>
			<td>H4784</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>HDS 029</td>
			<td>Tocris</td>
			<td>2646</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>PD 153035</td>
			<td>Tocris</td>
			<td>1037</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>PD 158780</td>
			<td>Tocris</td>
			<td>2615</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>PD 173074</td>
			<td>Tocris</td>
			<td>3044</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>PD 161570</td>
			<td>Tocris</td>
			<td>3724</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>PD 166285</td>
			<td>Tocris</td>
			<td>3785</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>BCA assay</td>
			<td>Pierce</td>
			<td>23225</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Phosphate-Buffer Saline (PBS)</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Pipettes and pipette tips</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Gloves</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Deionized or distilled water</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Flat-tipped tweezers</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Rocking platform shaker</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Microcentrifuge</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Plastic containers with the capacity to hold 50 ml</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>For washing arrays</td>
		</tr>
		<tr>
			<td>Plastic transparent sheet protector</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Plastic wrap</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Absorbent lab wipes</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Paper towels</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Autoradiography cassette</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Film developer</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Kodak BioMax Light Film</td>
			<td>Carestream Health</td>
			<td>178 8207</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Film developer</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Image Station 4000MM PRO</td>
			<td>Carestream Health</td>
			<td>&nbsp;</td>
			<td>Chemiluminescence imager compatible with collection of western data may be used instead of film and a film developer.</td>
		</tr>
		<tr>
			<td>Epson Perfection Scanner</td>
			<td>Epson</td>
			<td>V750 PRO</td>
			<td>Flatbed scanner with transparency adaptor capable of transmission mode</td>
		</tr>
		<tr>
			<td>Image Analysis Software</td>
			<td>GE,WesternVision, BioRad, Adobe, NIH, Protein Simple, etc</td>
			<td>&nbsp;</td>
			<td>ImageQuant, ArrayVision, Western Vision, Quantity One, Photoshop, ImageJ, AlphaView, or other compatible program</td>
		</tr>
		<tr>
			<td>Microsoft Excel</td>
			<td>Microsoft</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>Computer capable of running image analysis software and Microsoft Excel.</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
	</tbody>
</table>

profiling changes in receptor tyrosine kinase phosphorylation using antibody arrays - advertisement

Die Fehlregulation von Rezeptor-Tyrosin-Kinase (RTK) Expression und Phosphorylierung wird häufig mit der Entwicklung und Metastasierung von Krebszellen assoziiert. 1-3 erhebliche Anstrengungen auf die Entwicklung von Inhibitoren konzentriert auf bestimmte RTKs gezielt unterbrechen die aberrante Signalwege mit der Krankheit assoziierten Staaten . 4-7 Der Zweck dieser Studie war es, die Auswirkungen einer ausgewählten Anzahl von Inhibitoren auf RTK Phosphorylierung messen. In dieser Studie wurden die Human Phospho-RTK-Array, das eine Membran basierten Sandwich-Immunoassay Erhöhungen oder Verminderungen der Phosphorylierung für zahlreiche RTKs gleichzeitig überwachen in einer einzigen Probe ist. In diesem Assay präsentieren beide phosphorylierten und unphosphorylierten RTKs in einem Lysat Probe werden durch diskrete Antikörpern in Doppelbestimmung über eine Nitrocellulosemembran der Größe eines Mikroskop-Objektträger gedruckt eingefangen. Nach dem Waschen werden die Arrays mit Anti-Phospho-Tyrosin-Meerrettichperoxidase (HRP) inkubiert,die Sandwiches mit phosphorylierten RTKs auf dem Array erfasst. Nach einer zweiten Waschschritt werden die Arrays mit chemilumineszierenden Reagenzien inkubiert. Signal an jedem Array-Spot erzeugt wird, proportional zu der Menge an Phospho-Proteins durch jedes Fangantikörper gebunden. In diesen Experimenten wurden Arrays verwendet, um Erhöhungen der Phosphorylierung nach Ligandenstimulation von entweder MDA-MB-453 Brustkrebs oder KATO III Magenkarzinomzellen sowie zur Abnahme der Phosphorylierung bei der Behandlung von Zellen mit Inhibitoren selektiv gegenüber ErbB zugeordnet charakterisieren messen oder FGF R Familienmitglieder.

Proteome Profiler Antikörper-Arrays sind eine bequeme und kostengünstige Möglichkeit zum Screening auf Veränderungen in Rezeptor-Tyrosin-Kinase (RTK) Phosphorylierung ohne Durchführung zahlreicher Immunpräzipitation (IP) Westerns. Die ARY001 Menschliche RTK-Reihe läßt zur qualitativen Messung mehrerer RTKs in einer einzelnen Probe unter Verwendung von Chemilumineszenz-Detektion.

Profiling Veränderungen in Rezeptor Tyrosin Kinase-Phosphorylierung mit Antikörper Arrays - Werbung

The dysregulation of receptor tyrosine kinase (RTK) expression and phosphorylation is frequently associated with the development and metastatic spread of ...

profiling-changes-receptor-tyrosine-kinase-phosphorylation-using

Without Section

Profiling Changes in Receptor Tyrosine Kinase Phosphorylation using Antibody Arrays - ADVERTISEMENT

11.5K Aufrufe.  R&D Systems, Inc.. Proteome Profiler Antikörper-Arrays sind eine bequeme und kostengünstige Möglichkeit zum Screening auf Veränderungen in Rezeptor-Tyrosin-Kinase (RTK) Phosphorylierung ohne Durchführung zahlreicher Immunpräzipitation (IP) Westerns. Die ARY001 Menschliche RTK-Reihe läßt zur qualitativen Messung mehrerer RTKs in einer einzelnen Probe unter Verwendung von Chemilumineszenz-Detektion.

Serie: Profiling Veränderungen in Rezeptor Tyrosin Kinase-Phosphorylierung mit Antikörper Arrays - Werbung

Monitoring Protein Adsorption with Solid-state Nanopores

Solid-state nanopores have been used to perform measurements at the single-molecule level to examine the local structure and flexibility of nucleic acids 1-6, the unfolding of proteins 7, and binding affinity of different ligands 8. By coupling these nanopores to the resistive-pulse technique 9-12, such measurements can be done under a wide variety of conditions and without the need for labeling 3. In the resistive-pulse technique, an ionic salt solution is introduced on both sides of the nanopore. Therefore, ions are driven from one side of the chamber to the other by an applied transmembrane potential, resulting in a steady current. The partitioning of an analyte into the nanopore causes a well-defined deflection in this current, which can be analyzed to extract single-molecule information. Using this technique, the adsorption of single proteins to the nanopore walls can be monitored under a wide range of conditions 13. Protein adsorption is growing in importance, because as microfluidic devices shrink in size, the interaction of these systems with single proteins becomes a concern. This protocol describes a rapid assay for protein binding to nitride films, which can readily be extended to other thin films amenable to nanopore drilling, or to functionalized nitride surfaces. A variety of proteins may be explored under a wide range of solutions and denaturing conditions. Additionally, this protocol may be used to explore more basic problems using nanopore spectroscopy.

A method of using solid-state nanopores to monitor the non-specific adsorption of proteins onto an inorganic surface is described. The method employs the resistive-pulse principle, allowing for the adsorption to be probed in real-time and at the single-molecule level. Because the process of single protein adsorption is far from equilibrium, we propose the employment of parallel arrays of synthetic nanopores, enabling for the quantitative determination of the apparent first-order reaction rate constant of protein adsorption as well as and the Langmuir adsorption constant.

Überwachung Proteinadsorption mit Solid-State-Nanoporen

Solid-state nanopores have been used to perform measurements at the single-molecule level to examine the local structure and flexibility of nucleic acids ...

Forschung

JoVE Journal

Biotechnik

Determining the Phagocytic Activity of Clinical Antibody Samples

Antibody-driven phagocytosis is induced via the engagement of Fc receptors on professional phagocytes, and can contribute to both clearance as well as pathology of disease. While the properties of the variable domains of antibodies have long been considered critical to in vivo function, the ability of antibodies to recruit innate immune cells via their Fc domains has become increasingly appreciated as a major factor in their efficacy, both in the setting of recombinant monoclonal antibody therapy, as well as in the course of natural infection or vaccination1-3.
Importantly, despite its nomenclature as a constant domain, the antibody Fc domain does not have constant function, and is strongly modulated by IgG subclass (IgG1-4) and glycosylation at Asparagine 2974-6. Thus, this method to study functional differences of antigen-specific antibodies in clinical samples will facilitate correlation of the phagocytic potential of antibodies to disease state, susceptibility to infection, progression, or clinical outcome.
Furthermore, this effector function is particularly important in light of the documented ability of antibodies to enhance infection by providing pathogens access into host cells via Fc receptor-driven phagocytosis7. Additionally, there is some evidence that phagocytic uptake of immune complexes can impact the Th1/Th2 polarization of the immune response8.
Here, we describe an assay designed to detect differences in antibody-induced phagocytosis, which may be caused by differential IgG subclass, glycan structure at Asn297, as well as the ability to form immune complexes of antigen-specific antibodies in a high-throughput fashion. To this end, 1 &mu;m fluorescent beads are coated with antigen, then incubated with clinical antibody samples, generating fluorescent antigen specific immune complexes. These antibody-opsonized beads are then incubated with a monocytic cell line expressing multiple Fc&gamma;Rs, including both inhibitory and activating. Assay output can include phagocytic activity, cytokine secretion, and patterns of Fc&gamma;Rs usage, and are determined in a standardized manner, making this a highly useful system for parsing differences in this antibody-dependent effector function in both infection and vaccine-mediated protection9.

We present a high-throughput flow cytometric assay to determine the phagocytic activity of antigen-specific antibodies from clinical samples, utilizing fluorescent antigen-coated beads and a monocytic cell line expressing multiple Fc receptors&#x2014;providing receptor usage and phagocytic activity determinations in a standardized and reproducible fashion for any antigen of interest.

Die Bestimmung der Phagozytoseaktivität of Clinical Antikörper Proben

Antibody-driven phagocytosis is induced via the engagement of Fc receptors on professional phagocytes, and can contribute to both clearance as well as ...

Immunologie und Infektion

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

Cancer immunotherapy can harness the specificity of immune response to target and eliminate tumors. Adoptive cell therapy (ACT) based on the adoptive transfer of T cells genetically modified to express a chimeric antigen receptor (CAR) has shown considerable promise in clinical trials1-4. There are several advantages to using CAR+ T cells for the treatment of cancers including the ability to target non-MHC restricted antigens and to functionalize the T cells for optimal survival, homing and persistence within the host; and finally to induce apoptosis of CAR+ T cells in the event of host toxicity5.
Delineating the optimal functions of CAR+ T cells associated with clinical benefit is essential for designing the next generation of clinical trials. Recent advances in live animal imaging like multiphoton microscopy have revolutionized the study of immune cell function in vivo6,7. While these studies have advanced our understanding of T-cell functions in vivo, T-cell based ACT in clinical trials requires the need to link molecular and functional features of T-cell preparations pre-infusion with clinical efficacy post-infusion, by utilizing in vitro assays monitoring T-cell functions like, cytotoxicity and cytokine secretion. Standard flow-cytometry based assays have been developed that determine the overall functioning of populations of T cells at the single-cell level but these are not suitable for monitoring conjugate formation and lifetimes or the ability of the same cell to kill multiple targets8.
Microfabricated arrays designed in biocompatible polymers like polydimethylsiloxane (PDMS) are a particularly attractive method to spatially confine effectors and targets in small volumes9. In combination with automated time-lapse fluorescence microscopy, thousands of effector-target interactions can be monitored simultaneously by imaging individual wells of a nanowell array. We present here a high-throughput methodology for monitoring T-cell mediated cytotoxicity at the single-cell level that can be broadly applied to studying the cytolytic functionality of T cells.

We describe a single-cell high-throughput assay to measure cytotoxicity of T cells when incubated with tumor target cells. This method employs a dense, elastomeric array of sub-nanoliter wells (~100,000 wells/array) to spatially confine the T cells and target cells at defined ratios and is coupled to fluorescence microscopy to monitor effector-target conjugation and subsequent apoptosis.

Quantitative High-throughput Single-cell Zytotoxizitätstest für T-Zellen

Cancer immunotherapy can harness the specificity of  immune response to target and eliminate tumors. Adoptive cell therapy (ACT)  based on the adoptive ...

Automated Quantification of Synaptic Fluorescence in C. elegans

Synapse strength refers to the amplitude of postsynaptic responses to presynaptic neurotransmitter release events, and has a major impact on overall neural circuit function. Synapse strength critically depends on the abundance of neurotransmitter receptors clustered at synaptic sites on the postsynaptic membrane. Receptor levels are established developmentally, and can be altered by receptor trafficking between surface-localized, subsynaptic, and intracellular pools, representing important mechanisms of synaptic plasticity and neuromodulation. Rigorous methods to quantify synaptically-localized neurotransmitter receptor abundance are essential to study synaptic development and plasticity. Fluorescence microscopy is an optimal approach because it preserves spatial information, distinguishing synaptic from non-synaptic pools, and discriminating among receptor populations localized to different types of synapses. The genetic model organism Caenorhabditis elegans is particularly well suited for these studies due to the small size and relative simplicity of its nervous system, its transparency, and the availability of powerful genetic techniques, allowing examination of native synapses in intact animals.
Here we present a method for quantifying fluorescently-labeled synaptic neurotransmitter receptors in C. elegans. Its key feature is the automated identification and analysis of individual synapses in three dimensions in multi-plane confocal microscope output files, tabulating position, volume, fluorescence intensity, and total fluorescence for each synapse. This approach has two principal advantages over manual analysis of z-plane projections of confocal data. First, because every plane of the confocal data set is included, no data are lost through z-plane projection, typically based on pixel intensity averages or maxima. Second, identification of synapses is automated, but can be inspected by the experimenter as the data analysis proceeds, allowing fast and accurate extraction of data from large numbers of synapses. Hundreds to thousands of synapses per sample can easily be obtained, producing large data sets to maximize statistical power. Considerations for preparing C. elegans for analysis, and performing confocal imaging to minimize variability between animals within treatment groups are also discussed. Although developed to analyze C. elegans postsynaptic receptors, this method is generally useful for any type of synaptically-localized protein, or indeed, any fluorescence signal that is localized to discrete clusters, puncta, or organelles.
The procedure is performed in three steps: 1) preparation of samples, 2) confocal imaging, and 3) image analysis. Steps 1 and 2 are specific to C. elegans, while step 3 is generally applicable to any punctate fluorescence signal in confocal micrographs.

Automated Quantification of Synaptic Fluorescence in C. elegans

The abundance of neurotransmitter receptors clustered at synapses strongly influences synaptic strength. This method quantifies fluorescently-labeled neurotransmitter receptors in three dimensions with single-synapse resolution in C. elegans, allowing hundreds of synapses to be rapidly characterized within a single sample without distortions introduced by z-plane projection.

Automatisierte Quantifizierung der Fluoreszenz-in Synaptic<em&gt; C elegans</em

Synapse strength refers to the amplitude of postsynaptic responses to presynaptic neurotransmitter release events, and has a major impact on overall ...

Neurowissenschaften

Antibody Profiling by Luciferase Immunoprecipitation Systems (LIPS)

Technologies for comprehensively understanding and quantifying antibody profiles to autoantigens and infectious agents may yield new insights into disease mechanisms and may elucidate new markers to substratify disease with different clinical features and better understand pathogenesis. We have developed a highly quantitative method called Luciferase Immunoprecipitation Systems (LIPS) for profiling patient sera antibody responses to autoantigens and pathogen antigens associated with infection. Unlike ELISAs, the highly sensitive LIPS is easily implemented to survey humoral serological response profiles to different antigens in a universal format and produces dynamic antibody titer ranges up to 6 log10 for some antigens. In these studies, quantitative profiling by LIPS of patient humoral responses against panels of antigens or even the entire proteome of some pathogens (i.e. HIV), is typically more informative than testing a single antigen by ELISA. In addition, LIPS also eliminates time and effort needed to produce highly purified antigens as well as the labor-intensive assay optimization steps needed for standard ELISAs. Here we provide a detailed protocol describing the technical aspects of performing LIPS assays for readily profiling antibody responses to single or multiple antigens.

Antibody Profiling by Luciferase Immunoprecipitation Systems LIPS

The technical aspects of performing LIPS (Luciferase Immunoprecipitation Systems) are described. The overall approach involves expressing chimeric genes encoding antigens fused to Renilla luciferase (Ruc) in mammalian cells. Crude Ruc-antigen extracts are then prepared and, without purification, employed in immunoprecipitation assays to quantify antibodies.

Antikörper Profiling von Luciferase Immunpräzipitation Systems (LIPS)

Technologies for comprehensively understanding and quantifying antibody profiles to autoantigens and infectious agents may yield new insights into disease ...

Biologie

Western Blotting: Sample Preparation to Detection

Western blotting is an analytical technique used to detect specific proteins in a given sample of tissue homogenate or extract. It uses gel electrophoresis to separate native or denatured proteins by the length of the polypeptide (denaturing conditions) or by the 3-D structure of the protein (native/ non-denaturing conditions). The proteins are then transferred to a membrane (typically nitrocellulose or PVDF), where they are probed (detected) using antibodies specific to the target protein.

Western blotting is an analytical technique used to detect specific proteins in a given sample of tissue homogenate or extract.

Western Blot: Probenvorbereitung zur Detektion

Western blotting is an analytical technique used to detect specific proteins in a given sample of tissue homogenate or extract. It uses gel ...

Mutagenesis and Analysis of Genetic Mutations in the GC-rich KISS1 Receptor Sequence Identified in Humans with Reproductive Disorders

The kisspeptin receptor (KISS1R) is a G protein-coupled receptor recognized as the trigger of puberty and a regulator of reproductive competence in adulthood 1,2,3. Inactivating mutations in KISS1R identified in patients have been associated with iodiopathic hypogonadotropic hypogonadism (IHH) 1,2 and precocious puberty 4. Functional studies of these mutants are crucial for our understanding of the mechanisms underlying the regulation of reproduction by this receptor as well as those shaping the disease outcomes, which result from abnormal KISS1R signaling and function. However, the highly GC-rich sequence of the KISS1R gene makes it rather difficult to introduce mutations or amplify the gene encoding this receptor by PCR.
Here we describe a method to introduce mutations of interest into this highly GC-rich sequence that has been used successfully to generate over a dozen KISS1R mutants in our laboratory. We have optimized the PCR conditions to facilitate the amplification of a range of KISS1R mutants that include substitutions, deletions or insertions in the KISS1R sequence. The addition of a PCR enhancer solution, as well as of a small percentage of DMSO were especially helpful to improve amplification. This optimized procedure may be useful for other GC-rich templates as well.
The expression vector encoding the KISS1R is been used to characterize signaling and function of this receptor in order to understand how mutations may change KISS1R function and lead to the associated reproductive phenotypes. Accordingly, potential applications of KISS1R mutants generated by site-directed mutagenesis can be illustrated by many studies 1,4,5,6,7,8. As an example, the gain-of-function mutation in the KISS1R (Arg386Pro), which is associated with precocious puberty, has been shown to prolong responsiveness of the receptor to ligand stimulation 4 as well as to alter the rate of degradation of KISS1R 9. Interestingly, our studies indicate that KISS1R is degraded by the proteasome, as opposed to the classic lysosomal degradation described for most G protein-coupled receptors 9. In the example presented here, degradation of the KISS1R is investigated in Human Embryonic Kidney Cells (HEK-293) transiently expressing Myc-tagged KISS1R (MycKISS1R) and treated with proteasome or lysosome inhibitors. Cell lysates are immunoprecipitated using an agarose-conjugated anti-myc antibody followed by western blot analysis. Detection and quantification of MycKISS1R on blots is performed using the LI-COR Odyssey Infrared System. This approach may be useful in the study of the degradation of other proteins of interest as well.

Mutations in the kisspeptin receptor (KISS1R) are associated with reproductive disorders in patients. Here we describe how to introduce mutations of interest in the GC-rich sequence of KISS1R as well as the use of KISS1R constructs to characterize the degradation pathway of the receptor by immunoprecipitation and western blot.

Mutagenese und Analyse von genetischen Mutationen in den GC-reichen KISS1 Rezeptor-Sequenz in Menschen mit Fortpflanzungsstörungen Identified

The kisspeptin receptor (KISS1R) is a G protein-coupled receptor recognized as the trigger of puberty and a regulator of reproductive competence in ...

Monitoring Kinase and Phosphatase Activities Through the Cell Cycle by Ratiometric FRET

F&ouml;rster resonance energy transfer (FRET)-based reporters1 allow the assessment of endogenous kinase and phosphatase activities in living cells. Such probes typically consist of variants of CFP and YFP, intervened by a phosphorylatable sequence and a phospho-binding domain. Upon phosphorylation, the probe changes conformation, which results in a change of the distance or orientation between CFP and YFP, leading to a change in FRET efficiency (Fig 1). Several probes have been published during the last decade, monitoring the activity balance of multiple kinases and phosphatases, including reporters of PKA2, PKB3, PKC4, PKD5, ERK6, JNK7, Cdk18, Aurora B9 and Plk19. Given the modular design, additional probes are likely to emerge in the near future10. 
Progression through the cell cycle is affected by stress signaling pathways 11. Notably, the cell cycle is regulated differently during unperturbed growth compared to when cells are recovering from stress12.Time-lapse imaging of cells through the cell cycle therefore requires particular caution. This becomes a problem particularly when employing ratiometric imaging, since two images with a high signal to noise ratio are required to correctly interpret the results. Ratiometric FRET imaging of cell cycle dependent changes in kinase and phosphatase activities has predominately been restricted to sub-sections of the cell cycle8,9,13,14.
Here, we discuss a method to monitor FRET-based probes using ratiometric imaging throughout the human cell cycle. The method relies on equipment that is available to many researchers in life sciences and does not require expert knowledge of microscopy or image processing.

FRET-based reporters are increasingly used to monitor kinase and phosphatase activities in live cells. Here we describe a method on how to use FRET-based reporters to assess cell cycle-dependent changes in target phosphorylation.

Überwachung Kinase und Phosphatase-Aktivitäten durch den Zellzyklus durch Ratiometric FRET

F&ouml;rster resonance energy transfer (FRET)-based reporters1 allow the assessment of endogenous kinase and phosphatase activities in living cells. Such ...

Assaying the Kinase Activity of LRRK2 in vitro

Leucine Rich Repeat Kinase 2 (LRRK2) is a 2527 amino acid member of the ROCO family of proteins, possessing a complex, multidomain structure including a GTPase domain (termed ROC, for Ras of Complex proteins) and a kinase domain1. The discovery in 2004 of mutations in LRRK2 that cause Parkinson's disease (PD) resulted in LRRK2 being the focus of a huge volume of research into its normal function and how the protein goes awry in the disease state2,3. Initial investigations into the function of LRRK2 focused on its enzymatic activities4-6. Although a clear picture has yet to emerge of a consistent alteration in these due to mutations, data from a number of groups has highlighted the importance of the kinase activity of LRRK2 in cell death linked to mutations7,8. Recent publications have reported inhibitors targeting the kinase activity of LRRK2, providing a key experimental tool9-11. In light of these data, it is likely that the enzymatic properties of LRRK2 afford us an important window into the biology of this protein, although whether they are potential drug targets for Parkinson's is open to debate.
A number of different approaches have been used to assay the kinase activity of LRRK2. Initially, assays were carried out using epitope tagged protein overexpressed in mammalian cell lines and immunoprecipitated, with the assays carried out using this protein immobilised on agarose beads4,5,7. Subsequently, purified recombinant fragments of LRRK2 in solution have also been used, for example a GST tagged fragment purified from insect cells containing residues 970 to 2527 of LRRK212. Recently, Dani&euml;ls et al. reported the isolation of full length LRRK2 in solution from human embryonic kidney cells, however this protein is not widely available13. In contrast, the GST fusion truncated form of LRRK2 is commercially available (from Invitrogen, see table 1 for details), and provides a convenient tool for demonstrating an assay for LRRK2 kinase activity. Several different outputs for LRRK2 kinase activity have been reported. Autophosphorylation of LRRK2 itself, phosphorylation of Myelin Basic Protein (MBP) as a generic kinase substrate and phosphorylation of an artificial substrate - dubbed LRRKtide, based upon phosphorylation of threonine 558 in Moesin - have all been used, as have a series of putative physiological substrates including &alpha;-synuclein, Moesin and 4-EBP14-17. The status of these proteins as substrates for LRRK2 remains unclear, and as such the protocol described below will focus on using MBP as a generic substrate, noting the utility of this system to assay LRRK2 kinase activity directed against a range of potential substrates.

Assaying the Kinase Activity of LRRK2 in vitro

Leucine Rich Repeat Kinase 2 is a large multidomain kinase, mutations in which are the most common genetic cause of Parkinson's disease. Analysis of the kinase activity of this protein has proven to be a crucial tool in understanding the biology and dysfunction of this protein. In this paper, in vitro assaying of the kinase activity of LRRK2 and a selection of its mutants is described, providing an experimental system to examine phosphorylation of putative substrates and potential dysfunction of LRRK2 in disease.

Untersuchen der Kinase-Aktivität von LRRK2 In-vitro-</em

Leucine Rich Repeat Kinase 2 (LRRK2) is a 2527 amino acid member of the ROCO family of proteins, possessing a complex, multidomain structure including a ...

Design and Use of Multiplexed Chemostat Arrays

Chemostats are continuous culture systems in which cells are grown in a tightly controlled, chemically constant environment where culture density is constrained by limiting specific nutrients.1,2 Data from chemostats are highly reproducible for the measurement of quantitative phenotypes as they provide a constant growth rate and environment at steady state. For these reasons, chemostats have become useful tools for fine-scale characterization of physiology through analysis of gene expression3-6 and other characteristics of cultures at steady-state equilibrium.7 Long-term experiments in chemostats can highlight specific trajectories that microbial populations adopt during adaptive evolution in a controlled environment. In fact, chemostats have been used for experimental evolution since their invention.8 A common result in evolution experiments is for each biological replicate to acquire a unique repertoire of mutations.9-13 This diversity suggests that there is much left to be discovered by performing evolution experiments with far greater throughput. 
We present here the design and operation of a relatively simple, low cost array of miniature chemostats&mdash;or ministats&mdash;and validate their use in determination of physiology and in evolution experiments with yeast. This approach entails growth of tens of chemostats run off a single multiplexed peristaltic pump. The cultures are maintained at a 20 ml working volume, which is practical for a variety of applications. It is our hope that increasing throughput, decreasing expense, and providing detailed building and operation instructions may also motivate research and industrial application of this design as a general platform for functionally characterizing large numbers of strains, species, and growth parameters, as well as genetic or drug libraries.

We developed and validated a small-footprint array of miniature chemostats built from readily available parts for low cost. Physiological and experimental evolution results were similar to larger volume chemostats. The ministat array provides a compact, inexpensive, and accessible platform for traditional chemostat experiments, functional genomics, and chemical screening applications.

Design und die Verwendung Multiplexed Chemostat Arrays

Chemostats are continuous culture systems in which cells are grown in a tightly controlled, chemically constant environment where culture density is ...